Merritronix - Signs Mou With Analinear Design Technologies and Stuam Technologies
SES AI Announces Inclusion in Russell 3000®Index
Jagsonpal Pharmaceuticals - to Buy 85% Stake in Aequitas Healthcare
Jagsonpal Pharmaceuticals Ltd - Cost of Acquisition 208 Mln Rupees
Venu Joins Russell 3000 and Russell 2000 Indexes
NetraMark Signs New Netraai Clinical Trial Analysis Agreement With Late-Stage Biopharmaceutical Company
NetraMark Holdings - to Deploy Netraai Platform for Clinical Trial Data Analysis
Nanjing Vazyme Biotech Says Shareholder Plans to Unload up to 3% Stake in Co Between July 22 and Oct 21
VersaBank Launches Breakthrough Real-Time Structured Receivable Program to Point-of-Sale Industry in Canada and United States
Rocket Lab Corp - Proposed Deal for Enterprise Value for Iridium of Approximately $8.0 Bln
Rocket Lab Corp - Rocket Lab Will Acquire All Outstanding Shares of Iridium Common Stock for $54 per Share in a Cash and Stock Transaction
Rocket Lab to Acquire Iridium in Historic Deal, Creating a Fully Vertically Integrated Space Powerhouse Primed for Growth
BioCryst Sharpens Scientific Focus on External Innovation With Wind Down of Internal Discovery Programs and Closure of Birmingham Research Facility
BioCryst Pharmaceuticals - Shifts Strategic Focus to External Innovation for Rare Disease Pipeline
BioCryst Pharmaceuticals - Completes Enrollment in Phase 3 Alpha-Orbit Study for Navenibart